ClearOne Inc. (CLRO) — Research Summary as of August 6, 2026

Key Recent Catalysts (Last ~1–3 Months)

1. Merger Agreement with Cortigent / Vivani Medical (July 2, 2026)

The single most significant recent catalyst is ClearOne's announcement on July 2, 2026 that it entered into a definitive merger agreement with Cortigent, Inc., a wholly-owned subsidiary of Vivani Medical [5]. Under the terms, existing ClearOne shareholders are expected to own roughly 12.7%–14.4% of the combined company post-merger [2]. This news immediately drove dramatic price action: before the Cortigent announcement, CLRO was trading around the low-$3 range [4], and on July 7 the stock surged between ~24% and ~52% intraday as the market digested the deal [3][4].